Non‐selective NSAIDs vs selective cyclo‐oxygenase‐2 inhibitors
Total adverse events · acute gout
Non‐selective NSAIDs probably leads to higher total adverse events compared with selective cyclo‐oxygenase‐2 inhibitors (moderate certainty).
1 finding from 1 review
- RR 1.94 [1.36, 2.78]Studies not reportedModerate